NovoLog Mix 70/30 FlexPen and Ranibizumab
Determining the interaction of NovoLog Mix 70/30 FlexPen and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog Mix 70/30 FlexPen-Ranibizumab Intraocular
- NovoLog Mix 70/30 FlexPen-Ranibizumab ophthalmic
- NovoLog Mix 70/30 FlexPen-Ranitidine
- NovoLog Mix 70/30 FlexPen-Ranitidine Capsule
- NovoLog Mix 70/30 FlexPen-Ranitidine Hydrochloride
- NovoLog Mix 70/30 FlexPen-Ranitidine Injection
- Ranibizumab-NovoLog PenFill
- Ranibizumab-Novoseven
- Ranibizumab-NovoSeven RT
- Ranibizumab-NovoSeven RT with MixPro injection
- Ranibizumab-Novothyrox
- Ranibizumab-Noxafil